Claims
- 1. A process for preserving and augmenting innate immune defenses in humans and animals by the administration of a therapeutically effective amount of one or more chemical compositions defined as:
- 2. A process as defined in claim 1, further comprising the administration of a therapeutically effective amount of one or more chemical compositions defined as:
- 3. A process as defined in claim 1, wherein said administered chemical composition comprises a daily dosage of between about 5 mcg and about 60 mg.
- 4. A process as defined in claim 1, wherein the administered chemical composition comprises a daily dosage of 15 mg.
- 5. A process as defined in claim 1, wherein said administered chemical composition comprises a daily dosage individualized to body weight of between about 5 mg/kg and about 40 mg/kg.
- 6. A process as defined in claim 1, wherein said administered chemical composition comprises a daily dosage individualized to body weight of 25 mg/kg.
- 7. A process as defined in claim 1, wherein said animal is selected from the group consisting of fish, bird, reptile and mammal.
- 8. A process as defined in claim 1, wherein at least one of said chemical compositions is obtained from one or more monocotyledonous plants selected from the group consisting of corn, wheat, barley, rye, oats, rice, sorghum, millet, bamboo, Job's Tears, barley-like grasses, and wild grasses, by growing the plant to an immature life history stage and harvesting the plant.
- 9. A process as defined in claim 8, wherein said harvested plant is dried.
- 10. A process as defined in claim 9, wherein said harvested plant is dried at a temperature in the range of between about 40° C. and about 45° C.
- 11. A process as defined in claim 9, wherein said dried harvested plant contains phenols in total amounts greater than 17.0 mg/gm (dry weight).
- 12. A process as defined in claim 9, wherein said dried harvested plant contains combined amounts of 4-hydroxycinnamic acid and 4-hydroxy-3-methoxycinnamic acid totaling no more than 1.5 mg/gm (dry weight).
- 13. A process as defined in claim 8, wherein said harvested plant is immature corn, Zea mays.
- 14. A process as defined in claim 13, wherein said immature corn has been grown to a height between about 45 centimeters and about 122 centimeters.
- 15. A process as defined in claim 13, wherein said immature corn has been grown to a height that does not exceed between about 30 centimeters and about 45 centimeters.
- 16. A process as defined in claim 13, wherein said immature corn has been grown formless than ten weeks after planting.
- 17. A process as defined in claim 1, wherein said chemical composition is administered in a manner selected from the group consisting of: (1) orally, in the form of tablets, capsules, suspensions, solutions and other means suitable for ingestion, including sublingual dosage forms; (2) intranasal administration; (3) transmucosal administration; (4) parenteral injection, in the form of subcutaneous, intramuscular, intravenous; (5) implant for sustained release; and (6) transdermal patch.
- 18. A process for preserving and augmenting innate immune defenses in humans and animals by the administration of a therapeutically effective amount of one or more chemical compositions defined as:
- 19. A process as defined in claim 18, wherein one of said chemical compositions comprise 6-methoxy-2,3-benzoxazolinone defined as:
- 20. A process as defined in claim 18, wherein one of said chemical compositions comprise 5-methoxy-2,3-benzoxazolinone defined as:
- 21. A process as defined in claim 20, wherein said administered chemical composition comprises a daily dosage of between about 5 mcg and about 60 mg.
- 22. A process as defined in claim 19, wherein the administered chemical composition comprises a daily dosage of 15 mg.
- 23. A process as defined in claim 18, wherein said administered chemical composition comprises a daily dosage individualized to body weight of between about 5 mg/kg and about 40 mg/kg.
- 24. A process as defined in claim 18, wherein said administered chemical composition comprises a daily dosage individualized to body weight of 25 mg/kg.
- 25. A process as defined in claim 18, wherein said animal is selected from the group consisting of fish, bird, reptile and mammal.
- 26. A process as defined in claim 18, wherein at least one of said chemical compositions is obtained from one or more monocotyledonous plants selected from the group consisting of corn, wheat, barley, rye, oats, rice, sorghum, millet, bamboo, Job's Tears, barley-like grasses, and wild grasses, by growing the plant to an immature life history stage and harvesting the plant.
- 27. A process as defined in claim 26, wherein said harvested plant is dried.
- 28. A process as defined in claim 27, wherein said harvested plant is dried at a temperature in the range of between about 40° C. and about 45° C.
- 29. A process as defined in claim 27, wherein said dried harvested plant contains phenols in total amounts greater than 17.0 mg/gm (dry weight).
- 30. A process as defined in claim 27, wherein said dried harvested plant contains combined amounts of 4-hydroxycinnamic acid and 4-hydroxy-3-methoxycinnamic acid totaling no more than 1.5 mg/gm (dry weight).
- 31. A process as defined in claim 26, wherein said harvested plant is immature corn, Zea mays.
- 32. A process as defined in claim 31, wherein said immature corn has been grown to a height between about 45 centimeters and about 122 centimeters.
- 33. A process as defined in claim 31, wherein said immature corn has been grown to a height that does not exceed between about 30 centimeters and about 45 centimeters.
- 34. A process as defined in claim 31, wherein said immature corn has been grown for less than ten weeks after planting.
- 35. A process as defined in claim 18, wherein said chemical composition is administered in a manner selected from the group consisting of: (1) orally, in the form of tablets, capsules, suspensions, solutions and other means suitable for ingestion, including sublingual dosage forms; (2) intranasal administration; (3) transmucosal administration; (4) parenteral injection, in the form of subcutaneous, intramuscular, intravenous; (5) implant for sustained release; and (6) transdermal patch.
- 36. A process for preserving and augmenting innate immune defenses in humans and animals by the administration of a therapeutically effective amount of one or more chemical compositions defined as:
- 37. A process as defined in claim 36, wherein said administered chemical composition comprises a daily dosage of between about 5 mcg and about 60 mg.
- 38. A process as defined in claim 36, wherein the administered chemical composition comprises a daily dosage of 15 mg.
- 39. A process as defined in claim 36, wherein said administered chemical composition comprises a daily dosage individualized to body weight of between about 5 mg/kg and about 40 mg/kg.
- 40. A process as defined in claim 36, wherein said administered chemical composition comprises a daily dosage individualized to body weight of 25 mg/kg.
- 41. A process as defined in claim 36, wherein said animal is selected from the group consisting of fish, bird, reptile and mammal.
- 42. A process as defined in claim 36, wherein at least one of said chemical compositions is obtained from one or more monocotyledonous plants selected from the group consisting of corn, wheat, barley, rye, oats, rice, sorghum, millet, bamboo, Job's Tears, barley-like grasses, and wild grasses, by growing the plant to an immature life history stage and harvesting the plant.
- 43. A process as defined in claim 42, wherein said harvested plant is dried.
- 44. A process as defined in claim 43, wherein said harvested plant is dried at a temperature in the range of between about 40° C. and about 45° C.
- 45. A process as defined in claim 43, wherein said dried harvested plant contains phenols in total amounts greater than 17.0 mg/gm (dry weight).
- 46. A process as defined in claim 43, wherein said dried harvested plant contains combined amounts of 4-hydroxycinnamic acid and 4-hydroxy-3-methoxycinnamic acid totaling no more than 1.5 mg/gm (dry weight).
- 47. A process as defined in claim 42, wherein said harvested plant is immature corn, Zea mays.
- 48. A process as defined in claim 47, wherein said immature corn has been grown to a height between about 45 centimeters and about 122 centimeters.
- 49. A process as defined in claim 47, wherein said immature corn has been grown 5 to a height that does not exceed between about 30 centimeters and about 45 centimeters.
- 50. A process as defined in claim 47, wherein said immature corn has been grown for less than ten weeks after planting.
- 51. A process as defined in claim 36, wherein said chemical composition is administered in a manner selected from the group consisting of: (1) orally, in the form of tablets, capsules, suspensions, solutions and other means suitable for ingestion, including sublingual dosage forms; (2) intranasal administration; (3) transmucosal administration; (4) parenteral injection, in the form of subcutaneous, intramuscular, intravenous; (5) implant for sustained release; and (6) transdermal patch.
RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. patent application Ser. No. 10/718,232, filed Nov. 20, 2003, and entitled “NOVEL COMPOUNDS FOR USE IN WEIGHT LOSS AND APPETITE SUPPRESSION IN HUMANS,” which claims the benefit of U.S. patent application Ser. No. 09/834,592, filed Apr. 13, 2001, and entitled “NOVEL COMPOUNDS FOR USE AS ANTIDEPRESSANTS, APHRODISIACS, AND ADJUNCTIVE THERAPIES IN HUMANS,” now issued as U.S. Pat. No. 6,667,308, which claims the benefit of U.S. provisional application Serial No. 60/196,829, filed Apr. 13, 2000, and entitled “ANTIDEPRESSANT, APHRODISIAC, WEIGHT-LOSS AIDE, THERAPY FOR QUITTING NICOTINE OR ADDICTIVE DRUGS AND TREATMENT OF BETTERING REPRODUCTION IN HUMANS,” all of which are hereby incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60196829 |
Apr 2000 |
US |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
10718232 |
Nov 2003 |
US |
Child |
10845388 |
May 2004 |
US |
Parent |
09834592 |
Apr 2001 |
US |
Child |
10718232 |
Nov 2003 |
US |